TITLE

Expression of O6-methylguanine DNA methyltransferase (MGMT) and its clinical significance in gastroenteropancreatic neuroendocrine neoplasm

AUTHOR(S)
Qiu-Chen Yang; Yu-Hong Wang; Yuan Lin; Ling Xue; Yuan-Jia Chen; Min-Hu Chen; Jie Chen
PUB. DATE
July 2014
SOURCE
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 7, p4204
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
97436086

 

Related Articles

  • Multiple Assays to Determine Methylguanine-Methyltransferase Status in Lung Carcinoids and Correlation with Clinical and Pathological Features. Vatrano, Simona; Giorcelli, Jessica; Votta, Arianna; Capone, Guendalina; Izzo, Stefania; Gatti, Gaia; Righi, Luisella; Napoli, Francesca; Scagliotti, Giorgio; Papotti, Mauro; Volante, Marco; Rapa, Ida // Neuroendocrinology;2020, Vol. 110 Issue 1/2, p1 

    Background: O6-methylguanine-methyltransferase (MGMT) is a key enzyme for the DNA repair machinery strongly associated with response to alkylating agents in different tumors. Data on its expression and related clinical impact in neuroendocrine tumors are limited to the gastro-entero-pancreatic...

  • Prognostic and Predictive Roles of MGMT Protein Expression and Promoter Methylation in Sporadic Pancreatic Neuroendocrine Neoplasms. Schmitt, anja Maria; Pavel, Marianne; Rudolph, Thomas; Dawson, Heather; Blank, annika; Komminoth, Paul; Vassella, Erik; Perren, aurel // Neuroendocrinology;Nov2014, Vol. 100 Issue 1, p35 

    Background/Aims: O6-methylguanine-methyltransferase (MGMT) is an important enzyme of DNA repair. MGMT promoter methylation is detectable in a subset of pancreatic neuroendocrine neoplasms (pNEN). A subset of pNEN responds to the alkylating agent temozolomide (TMZ). We wanted to correlate MGMT...

  • Promoter hypermethylation of O6 -methylguanine-DNA methyltransferase gene in cholangiocarcinoma. Liu Xiao-fang; Sun Xian-chun; Zhang Cui-sheng; Xu Zheng; Li Shao-jun; Zhou Xian-ting; Sun Shi-jie // Journal of Chinese Clinical Medicine;2010, Vol. 5 Issue 8, p463 

    Objective O6-methylguanine-DNA methyltransferase(MGMT)is an effective DNA repair enzyme. The aberrant methylation of its promoter region CpG islands may be one of the important mechanisms of carcinogenesis. We studied the methylation status of MGMT gene and clinical significance in...

  • Promoter hypermethylation of O6 -methylguanine-DNA methyltransferase gene in cholangiocarcinoma. Liu Xiao-fang; Sun Xian-chun; Zhang Cui-sheng; Xu Zheng; Li Shao-jun; Zhou Xian-ting; Sun Shi-jie // Journal of Chinese Clinical Medicine;2010, Vol. 5 Issue 7, p463 

    Objective O6-methylguanine-DNA methyltransferase (MGMT) is an effective DNA repair enzyme. The aberrant methylation of its promoter region CpG islands may be one of the important mechanisms of carcinogenesis. We studied the methylation status of MGMT gene and clinical significance in...

  • MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area. Yousuf, Adfar; Bhat, Mohammad; Pandith, Arshad; Afroze, Dil; Khan, Nighat; Alam, Khursheed; Shah, Parveen; Shah, M.; Mudassar, Syed // Cellular Oncology (2211-3428);Aug2014, Vol. 37 Issue 4, p245 

    Purpose: Inactivation of tumor suppressor and DNA repair genes by promoter hypermethylation does commonly occur in human cancers. O-methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme that removes methyl groups as well as larger adducts at the O position of guanine. In the absence...

  • MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy. Melguizo, Consolaci¢n; Prados, Jose; Gonz lez, Beatriz; Ortiz, Raul; Concha, Angel; Alvarez, Pablo Juan; Madeddu, Roberto; Perazzoli, Gloria; Oliver, Jaime Antonio; L¢pez, Rodrigo; Rodr¡guez-Serrano, Fernando; Ar nega, Antonia // Journal of Translational Medicine;2012, Vol. 10 Issue 1, p250 

    Background: The CD133 antigen is a marker of radio- and chemo-resistant stem cell populations in glioblastoma (GBM). The O6-methylguanine DNA methyltransferase (MGMT) enzyme is related with temozolomide (TMZ) resistance. Our propose is to analyze the prognostic significance of the CD133 antigen...

  • Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas. Zhang, Jie; Yang, Jian-hui; Quan, Jia; Kang, Xing; Wang, Hui-juan; Dai, Peng-gao // Tumor Biology (Springer Science & Business Media B.V.);Oct2016, Vol. 37 Issue 10, p13571 

    O-methylguanine-DNA methyltransferase ( MGMT) gene promoter methylation was reported to be an independent prognostic and predictive factor in glioma patients who received temozolomide treatment. However, the predictive value of MGMT methylation was recently questioned by several large clinical...

  • Progression of O-methylguanine-DNA methyltransferase and temozolomide resistance in cancer research. Jiang, Guan; Jiang, Ai-Jun; Xin, Yong; Li, Lian-Tao; Cheng, Qian; Zheng, Jun-Nian // Molecular Biology Reports;Oct2014, Vol. 41 Issue 10, p6659 

    Temozolomide (TMZ) is an alkylating agent that is widely used in chemotherapy for cancer. A key mechanism of resistance to TMZ is the overexpression of O-methylguanine-DNA methyltransferase (MGMT). MGMT specifically repairs the DNA O-methylation damage induced by TMZ and irreversibly inactivates...

  • Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects. Koumarianou, anna; Kaltsas, Gregory; Kulke, Matthew H.; Oberg, Kjell; Strosberg, Jonathan R.; Spada, Francesca; Galdy, Salvatore; Barberis, Massimo; Fumagalli, Caterina; Berruti, alfredo; Fazio, Nicola // Neuroendocrinology;Jul2015, Vol. 101 Issue 4, p274 

    Alkylating agents, such as streptozocin and dacarbazine, have been reported as active in neuroendocrine neoplasms (NENs). Temozolomide (TMZ) is an oral, potentially less toxic derivative of dacarbazine, which has shown activity both as a single agent and in combination with other drugs....

  • O6-methylguanine-DNA methyltransferase as a prognostic and predictive marker for basal-like breast cancer treated with cyclophosphamide-based chemotherapy. SAYURI ISONO; MAKOTO FUJISHIMA; TATSUYA AZUMI; YUKIHIKO HASHIMOTO; YOSHIFUMI KOMOIKE; MASAO YUKAWA; MASAHIRO WATATANI // Oncology Letters;2014, Vol. 7 Issue 6, p1778 

    The O6-methylguanine-DNA methyltransferase (MGMT) protein protects cells from alkylating agents by removing alkyl groups from the O6-position of guanine. However, its effect on DNA damage induced by cyclophosphamide (CPM) is unclear. The present study investigated whether MGMT expression was...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics